MultiCorp Medical
A division of Multicorp International, Inc.
MultiCorp International, Inc. is focused on bringing the patented migraine medicine the company acquired a 70% stake in back in October
2014. Over the past 16 months we have contracted with several companies to further the drug to gain feedback from the FDA.

The company received a report back on our queries to the FDA and this has laid the groundwork for the company to go to Proof of
Concept clinical trials in an emergency room setting. This 4-Arm study will compare our medicine to the current one(s) in the marketplace.

The current U.S. market for migraine medications stand at over $800 Million and we’re fairly confident that since the medication we are
proposing, based on our patent, could achieve at least a 10-15% share of this market which translate to between $80-$120 Million. This is a
conservative estimate due to the near zero side effects the drug has shown in the past having been dispensed to over 1200 patients over
the last 11 years in a clinical setting. The company has high expectations this drug will become the norm in bringing relief to the migraine
sufferers here in the U.S. and eventually to the global market.

As we progress in developing this study and beginning the process, the company will look to partner with a larger pharmaceutical
company that will give us the distribution needed to bring the product to market, possible sooner than our goal of 2 years.
Migraine is an extraordinarily common disease that affects 38 million men, women and children in the United States. Almost everyone
either knows someone who has suffered from migraine, or has struggled with migraine themselves.

  • Nearly 1 in 4 U.S. households includes someone with migraine.
  • Amazingly, over 12% of the population - including children - suffers from migraine. That's more than diabetes and asthma combined!
  • About 18% of American women and 6% of men suffer from migraine.
  • Migraine is most common during the peak productive years, between the ages of 25 and 55.
  • Migraine tends to run in families. If one parent suffers from migraine, there is a 40% chance a child will suffer. If both parents suffer, the chance
    rises to 90%.

Many people do not realize how serious and debilitating migraine can be. In addition to attack-related disability, migraine interferes with a
sufferer's ability to function in everyday life, whether that is going to school or work, caring for family or enjoying social activities.

  • Migraine is the 8th most disabling illness in the world.
  • Every 10 seconds, someone in the United States goes to the emergency room with a headache or migraine.
  • While most sufferers experience attacks once or twice a month, 14 million people or about 4% have chronic daily headache, when attacks occur at
    least 15 days per month.
  • More than 90% of sufferers are unable to work or function normally during their migraine.

Migraine is not just a bad headache.

  • Migraine is an extremely debilitating collection of neurological symptoms.
  • Migraine is a severe recurring intense throbbing pain on one side of the head, although in about 1/3 of attacks, both sides are affected.
  • Attacks  are often accompanied by one or more of the following: visual disturbances, nausea, vomiting, dizziness, extreme sensitivity to sound, light,
    touch and smell, and tingling or numbness in the extremities or face.
  • In 15-20% of attacks, other neurological symptoms occur before the actual head pain.
  • Attacks usually last between 4 and 72 hours.

For many sufferers, migraine is a chronic disease that significantly diminishes their quality of life.

  • About 14 million people experience chronic daily headache – when attacks occur at least 15 days per month.
  • For more than 90% of all sufferers, migraine interferes with their education, career and social activities.
  • Depression, anxiety, and sleep disturbances are common for those with chronic migraine.

Migraine is a public health issue with serious social and economic repercussions.

  • American employers lose more than $13 billion each year as a result of 113 million lost work days due to migraine.
  • Chronic illness – a category into which migraine can fall - is one of the country's biggest healthcare challenges, and costs an estimated $50 billion
    per year.
  • Migraine sufferers, like those who suffer from other chronic illnesses, face the consequences of high costs of medical services, too little support,
    and limited access to quality care.
  • People with migraine use about twice the medical resources –including prescription medications and office and emergency room visits– as non-
    sufferers.


Source - Migraine Research Foundation